B

Epsilon-aminocaproic acid is an antifibrinolytic that can block the protective fibrinolysis occurring in disseminated intravascular coagulation and therefore is generally contraindicated, whereas heparin, blood component transfusion, and intravenous fluids are commonly employed as part of DIC management [Karpatkin, 1971, PMID 25868172].